tolazoline and Anemia, Sickle Cell
tolazoline has been researched along with Anemia, Sickle Cell in 2 studies
Tolazoline: A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.
tolazoline : A member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group.
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
SMITH, E | 1 |
ROSENBLATT, P | 1 |
BEDO, AV | 1 |
Chang, H | 1 |
Ewert, SM | 1 |
Nagel, RL | 1 |
Other Studies
2 other studies available for tolazoline and Anemia, Sickle Cell
Article | Year |
---|---|
Sickle-cell anemia crisis; report on seven patients treated with priscoline.
Topics: Anemia; Anemia, Sickle Cell; Erythrocytes, Abnormal; Humans; Sympatholytics; Tolazoline | 1953 |
Identification of 2-imidazolines as anti-sickling agents.
Topics: Anemia, Sickle Cell; Antisickling Agents; Clonidine; Gels; Hemoglobin, Sickle; Humans; Imidazoles; K | 1983 |